Vodcasts & Presentations
38th Critical Care Congress: Monotherapy Vs Combination Antimicrobial Therapy of Sepsis
During this session, the controversial debate on whether or not combination antimicrobial therapy is more efficacious than monotherapy for gram-negative bacteremia is presented. Although there are theoretical advantages to combination therapy, the data from studies of patients with gram-negative bacteraemias have been conflicting.
- Dennis G. Maki, MD, examines the evidence that modern monotherpy is sufficient
- Anand Kumar, MD, FCCM, examines the evidence that combination therapy yields improved outcomes
37th Critical Care Congress: The Cutting Edge of Sepsis Therapies
- Daniel Meldrum, MD, examines when and why to use beta-blockers in septic shock
- Sara S. Cheng, MD, presents on the use of anticoagulants in sepsis
- Jeffery S. Vender, MD, FCCM, discusses hemodynamic monitoring in sepsis
- Claudio Ronco, MD, assesses the role of hemofiltration in sepsis
- Jean-Louis Vincent, MD, PhD, FCCM, presents an evidenced-based approach to sepsis
37th Critical Care Congress: Selected Controversies in Sepsis Therapy in the PICU
- Jerry J. Zimmerman, MD, PhD FCCM, evaluates the role of steroid use in pediatric sepsis
- Vinay M. Nadkarni, MD, FCCM, discusses the approach to tight glycemic control in critically ill children
- Mark R. Rigby, MD, PhD, reviews the mechanisms and effects of tight glycemic control in children
- Joseph A. Carcillo, MD, describes the application of goal-directed therapy to pediatric septic shock
- Elizabeth A. Farrington, PharmD, reviews current information on the use of vasopressin in pediatric septic shock
37th Critical Care Congress: Hemodynamic Support of Sepsis
- Judith Jacobi, PharmD, FCCM, reviews the rationale for using various fluid products during the resuscitation of the septic patient, including the use of crystalloids versus colloids versus blood products
- Emanuel Rivers, MD, MPH, further explains early goal-directed therapy interventions for the patient with sepsis and how early treatment can reduce mortality
- Jean-Louis Vincent, MD, PhD, FCCM, discusses the results from clinical trials assessing the adequacy of resuscitation in the septic patient
- James Russell, MD, compares the rationales for vasopressin and norepinephrine in septic shock
EISCM
20th Annual Congress: Adjunctive Therapy of Sepsis
Watch Slide & Audio Presentation
